Lifetime prevention must start before conception - Report - MDSpire

Lifetime prevention must start before conception

  • By

  • Lilaf Abdulmajid

  • Sevda Ece Kizilkilic

  • Paul Dendale

  • February 18, 2026

  • 0 min

Share

Preventive Strategies for Cardiovascular Health Should Begin Prior to Conception

Overview

Cardiovascular disease prevention must start before conception, as parental health and pregnancy conditions critically influence lifelong cardiovascular risk for both mother and offspring. Early identification of vascular and metabolic disturbances during pregnancy offers actionable opportunities to alter disease trajectories across generations.

Background

Cardiovascular disease remains the leading cause of death globally, with traditional prevention often focused on adult risk factors or pregnancy complications. However, evidence shows that cardiovascular risk roots extend back to pre-conception and gestation periods, involving both maternal and paternal health. Epigenetic and placental biomarkers reveal early vascular programming that predisposes offspring to future cardiovascular disease, underscoring the need for a life-course prevention approach.

Data Highlights

Studies demonstrate that maternal pre-conception factors such as body mass, blood pressure, and glycemic control strongly predict pregnancy complications and future cardiovascular risk. Paternal obesity and smoking induce epigenetic changes affecting offspring lipid metabolism and vascular function. Placental lesions like acute atherosis correlate with maternal cardiovascular risk decades later. Altered methylation patterns in umbilical cord blood predict early vascular dysfunction and metabolic syndrome in children.

Key Findings

  • Pre-conception health in both mothers and fathers significantly influences offspring cardiovascular risk via epigenetic mechanisms.
  • Subclinical vascular dysfunction and metabolic disturbances during pregnancy program fetal cardiovascular health with lifelong consequences.
  • Placental pathology, including acute atherosis, serves as a biomarker linking pregnancy complications to maternal cardiovascular disease risk.
  • Current clinical care often delays cardiovascular risk assessment until after pregnancy or adulthood, missing critical early intervention windows.
  • Cross-specialty collaboration is essential to integrate cardiovascular risk assessment and prevention from pre-conception through postpartum and childhood.
  • The European Association of Preventive Cardiology advocates for a 'prevention from cradle to grave' model emphasizing early and continuous intervention.

Clinical Implications

Clinicians should incorporate cardiovascular risk assessment and management into pre-conception care for both women and men, setting actionable targets before pregnancy. During pregnancy, identification of vascular and placental biomarkers should prompt ongoing postpartum and pediatric surveillance to mitigate long-term cardiovascular risk. Multidisciplinary collaboration across primary care, cardiology, obstetrics, and pediatrics is critical to implement effective lifetime prevention strategies.

Conclusion

Shifting cardiovascular prevention upstream to include pre-conception and gestational periods is essential to interrupt the intergenerational transmission of risk. Early identification and intervention can transform outcomes, fulfilling the vision of true lifetime cardiovascular disease prevention.

References

  1. European Association of Preventive Cardiology (EAPC) -- Prevention from cradle to grave
  2. Studies on placental lesions and maternal cardiovascular risk -- PEARLS study
  3. Research on paternal epigenetic influences on offspring cardiovascular health

Original Source(s)

Related Content